- Endologix (OTCPK:ELGXQ) has received a CE Mark for the ALTO Abdominal Stent Graft System (ALTO).
- More news on: ENDOLOGIX INC, Healthcare stocks news, Read more ...
home / stock / elgxq / elgxq news
Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Endologix Inc. Company Name:
ELGXQ Stock Symbol:
Market:
Furthering its mission to transform the treatment of aortic disorders, Endologix, Inc. (OTC: ELGXQ) (“Endologix” or the “Company”) today announced the first implant of its recently approved ALTO ® endograft outside of the United States, completed by Andrew Ho...
Transforming the treatment of aortic disorders, Endologix ® Inc. (OTC: ELGXQ) (“Endologix” or the “Company”), today announced that it has received a CE Mark for the ALTO™ Abdominal Stent Graft System (ALTO). “We are very excited to receive a...